These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34481928)

  • 1. Complement opsonization of nanoparticles: Differences between humans and preclinical species.
    Li Y; Wang G; Griffin L; Banda NK; Saba LM; Groman EV; Scheinman R; Moghimi SM; Simberg D
    J Control Release; 2021 Oct; 338():548-556. PubMed ID: 34481928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of complement activation by dextran-coated superparamagnetic iron oxide (SPIO) nanoworms in mouse versus human serum.
    Banda NK; Mehta G; Chao Y; Wang G; Inturi S; Fossati-Jimack L; Botto M; Wu L; Moghimi SM; Simberg D
    Part Fibre Toxicol; 2014 Nov; 11():64. PubMed ID: 25425420
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Wang G; Griffin JI; Inturi S; Brenneman B; Banda NK; Holers VM; Moghimi SM; Simberg D
    Front Immunol; 2017; 8():151. PubMed ID: 28239384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability of Complement Response toward Preclinical and Clinical Nanocarriers in the General Population.
    Benasutti H; Wang G; Vu VP; Scheinman R; Groman E; Saba L; Simberg D
    Bioconjug Chem; 2017 Nov; 28(11):2747-2755. PubMed ID: 29090582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulatory Role of Surface Coating of Superparamagnetic Iron Oxide Nanoworms in Complement Opsonization and Leukocyte Uptake.
    Inturi S; Wang G; Chen F; Banda NK; Holers VM; Wu L; Moghimi SM; Simberg D
    ACS Nano; 2015 Nov; 9(11):10758-68. PubMed ID: 26488074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin deposition on biomolecule corona determines complement opsonization efficiency of preclinical and clinical nanoparticles.
    Vu VP; Gifford GB; Chen F; Benasutti H; Wang G; Groman EV; Scheinman R; Saba L; Moghimi SM; Simberg D
    Nat Nanotechnol; 2019 Mar; 14(3):260-268. PubMed ID: 30643271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement therapeutics meets nanomedicine: overcoming human complement activation and leukocyte uptake of nanomedicines with soluble domains of CD55.
    Gifford G; Vu VP; Banda NK; Holers VM; Wang G; Groman EV; Backos D; Scheinman R; Moghimi SM; Simberg D
    J Control Release; 2019 May; 302():181-189. PubMed ID: 30974134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C1q-Mediated Complement Activation and C3 Opsonization Trigger Recognition of Stealth Poly(2-methyl-2-oxazoline)-Coated Silica Nanoparticles by Human Phagocytes.
    Tavano R; Gabrielli L; Lubian E; Fedeli C; Visentin S; Polverino De Laureto P; Arrigoni G; Geffner-Smith A; Chen F; Simberg D; Morgese G; Benetti EM; Wu L; Moghimi SM; Mancin F; Papini E
    ACS Nano; 2018 Jun; 12(6):5834-5847. PubMed ID: 29750504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Human Complement System by Dextran-Coated Iron Oxide Nanoparticles Is Not Affected by Dextran/Fe Ratio, Hydroxyl Modifications, and Crosslinking.
    Wang G; Chen F; Banda NK; Holers VM; Wu L; Moghimi SM; Simberg D
    Front Immunol; 2016; 7():418. PubMed ID: 27777575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-relaxivity superparamagnetic iron oxide nanoworms with decreased immune recognition and long-circulating properties.
    Wang G; Inturi S; Serkova NJ; Merkulov S; McCrae K; Russek SE; Banda NK; Simberg D
    ACS Nano; 2014 Dec; 8(12):12437-49. PubMed ID: 25419856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle-Binding Immunoglobulins Predict Variable Complement Responses in Healthy and Diseased Cohorts.
    Li Y; Saba L; Scheinman RI; Banda NK; Holers M; Monte A; Dylla L; Moghimi SM; Simberg D
    ACS Nano; 2024 Oct; 18(42):28649-28658. PubMed ID: 39395006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combating Complement's Deleterious Effects on Nanomedicine by Conjugating Complement Regulatory Proteins to Nanoparticles.
    Wang Z; Hood ED; Nong J; Ding J; Marcos-Contreras OA; Glassman PM; Rubey KM; Zaleski M; Espy CL; Gullipali D; Miwa T; Muzykantov VR; Song WC; Myerson JW; Brenner JS
    Adv Mater; 2022 Feb; 34(8):e2107070. PubMed ID: 34910334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo.
    Chen F; Wang G; Griffin JI; Brenneman B; Banda NK; Holers VM; Backos DS; Wu L; Moghimi SM; Simberg D
    Nat Nanotechnol; 2017 May; 12(4):387-393. PubMed ID: 27992410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-Dependent Complement Responses toward SARS-CoV-2 Receptor-Binding Domain Immobilized on "Pseudovirus-like" Nanoparticles.
    Gaikwad H; Li Y; Wang G; Li R; Dai S; Rester C; Kedl R; Saba L; Banda NK; Scheinman RI; Patrick C; Mallela KMG; Moghimi SM; Simberg D
    ACS Nano; 2022 May; ():. PubMed ID: 35507641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The full expression of the ity phenotype in ityr mice requires C3 activation by Salmonella lipopolysaccharide.
    Nishikawa F; Yoshikawa S; Harada H; Kita M; Kita E
    Immunology; 1998 Dec; 95(4):640-7. PubMed ID: 9893057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of dot blot immunoassay for measurement of complement opsonization of nanoparticles.
    Li Y; Monte A; Dylla L; Moghimi SM; Simberg D
    J Immunol Methods; 2024 May; 528():113668. PubMed ID: 38574804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opsonization of bacteroides by the alternative complement pathway reconstructed from isolated plasma proteins.
    Bjornson AB; Magnafichi PI; Schreiber RD; Bjornson HS
    J Exp Med; 1987 Mar; 165(3):777-98. PubMed ID: 3819646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement.
    Verbrugh HA; Peterson PK; Nguyen BY; Sisson SP; Kim Y
    J Immunol; 1982 Oct; 129(4):1681-7. PubMed ID: 7108223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of acute complement responses towards bolus-injected nanoparticles using targeted short-circulating regulatory proteins.
    Li Y; Jacques S; Gaikwad H; Wang G; Banda NK; Holers VM; Scheinman RI; Tomlinson S; Moghimi SM; Simberg D
    Nat Nanotechnol; 2024 Feb; 19(2):246-254. PubMed ID: 37798566
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.